Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

SRR12202427

ed9c8e24-81f0-52fb-beda-5a7c605babce

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • OXIDATIVE_PHOSPHORYLATION+0.230
  • SPERMATOGENESIS+0.210
  • FATTY_ACID_METABOLISM+0.190
  • PANCREAS_BETA_CELLS+0.170
  • PEROXISOME+0.150
  • BILE_ACID_METABOLISM+0.120
  • ADIPOGENESIS+0.080
  • XENOBIOTIC_METABOLISM+0.080
  • KRAS_SIGNALING_DN-0.030
  • CHOLESTEROL_HOMEOSTASIS-0.120

Top 10 suppressed

  • TNFA_SIGNALING_VIA_NFKB-0.570
  • ANGIOGENESIS-0.540
  • INTERFERON_ALPHA_RESPONSE-0.530
  • TGF_BETA_SIGNALING-0.520
  • INTERFERON_GAMMA_RESPONSE-0.490
  • P53_PATHWAY-0.470
  • HYPOXIA-0.440
  • IL6_JAK_STAT3_SIGNALING-0.410
  • NOTCH_SIGNALING-0.390
  • INFLAMMATORY_RESPONSE-0.380

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

6 twins match this tumor's tissue · 4 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR12202450
bladder-landscape@3
0.929
2SRR934734
brain-umap@2
0.907
3SRR2700736
melanoma-umap@29
0.900
4SRR657348
brain-umap@2
GTEX0.895
5TCGA-E9-A245-01A-22R-A16F-07
breast-umap@18
B0.889
6SRR8943038
bladder-landscape@3
0.887
7SRR1367870
brain-umap@2
GTEX0.887
8SRR1324431
brain-umap@2
GTEX0.886
9TCGA-E5-A4U1-01A-11R-A31N-07
bladder-landscape@3
0.885
10SRR1471435
brain-umap@2
GTEX0.885

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 8 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
OXIDATIVE_PHOSPHORYLATION0.230Remibrutinib— uncovered
SPERMATOGENESIS0.210Inavolisib— uncovered
FATTY_ACID_METABOLISM0.190Inavolisib— uncovered
PANCREAS_BETA_CELLS0.170Cobimetinib— uncovered
PEROXISOME0.150Idelalisib— uncovered
BILE_ACID_METABOLISM0.120Inavolisib— uncovered
ADIPOGENESIS0.080Inavolisib— uncovered
XENOBIOTIC_METABOLISM0.080Inavolisib— uncovered